These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25382202)

  • 1. Impact of a stereocentre inversion in cyclic lipodepsipeptides from the viscosin group: a comparative study of the viscosinamide and pseudodesmin conformation and self-assembly.
    Geudens N; De Vleeschouwer M; Fehér K; Rokni-Zadeh H; Ghequire MG; Madder A; De Mot R; Martins JC; Sinnaeve D
    Chembiochem; 2014 Dec; 15(18):2736-46. PubMed ID: 25382202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane Interactions of Natural Cyclic Lipodepsipeptides of the Viscosin Group.
    Geudens N; Nasir MN; Crowet JM; Raaijmakers JM; Fehér K; Coenye T; Martins JC; Lins L; Sinnaeve D; Deleu M
    Biochim Biophys Acta Biomembr; 2017 Mar; 1859(3):331-339. PubMed ID: 28007479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viscosinamide, a new cyclic depsipeptide with surfactant and antifungal properties produced by Pseudomonas fluorescens DR54.
    Nielsen TH; Christophersen C; Anthoni U; Sørensen J
    J Appl Microbiol; 1999 Jul; 87(1):80-90. PubMed ID: 10432590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The solution structure and self-association properties of the cyclic lipodepsipeptide pseudodesmin A support its pore-forming potential.
    Sinnaeve D; Hendrickx PM; Van Hemel J; Peys E; Kieffer B; Martins JC
    Chemistry; 2009 Nov; 15(46):12653-62. PubMed ID: 19839018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis and Antimicrobial Activity of Pseudodesmin and Viscosinamide Cyclic Lipopeptides Produced by Pseudomonads Associated with the Cocoyam Rhizosphere.
    Oni FE; Geudens N; Adiobo A; Omoboye OO; Enow EA; Onyeka JT; Salami AE; De Mot R; Martins JC; Höfte M
    Microorganisms; 2020 Jul; 8(7):. PubMed ID: 32698413
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid total synthesis of cyclic lipodepsipeptides as a premise to investigate their self-assembly and biological activity.
    De Vleeschouwer M; Sinnaeve D; Van den Begin J; Coenye T; Martins JC; Madder A
    Chemistry; 2014 Jun; 20(25):7766-75. PubMed ID: 24817328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformation and Dynamics of the Cyclic Lipopeptide Viscosinamide at the Water-Lipid Interface.
    Geudens N; Kovács B; Sinnaeve D; Oni FE; Höfte M; Martins JC
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31213011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioconversion of waste glycerol into viscosinamide by Pseudomonas fluorescens DR54 and its activity evaluation.
    Jama D; Łaba W; Kruszelnicki M; Polowczyk I; Lazar Z; Janek T
    Sci Rep; 2024 Jan; 14(1):1531. PubMed ID: 38233450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPZPMs--a novel group of cyclic lipodepsipeptides produced by the Phytophthora alni associated strain Pseudomonas sp. JX090307--the missing link between the viscosin and amphisin group.
    Weisshoff H; Hentschel S; Zaspel I; Jarling R; Krause E; Pham TL
    Nat Prod Commun; 2014 Jul; 9(7):989-96. PubMed ID: 25230511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
    Lee DL; Hodges RS
    Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, chemistry, and biological activity of pseudophomins A and B, new cyclic lipodepsipeptides isolated from the biocontrol bacterium Pseudomonas fluorescens.
    Pedras MS; Ismail N; Quail JW; Boyetchko SM
    Phytochemistry; 2003 Apr; 62(7):1105-14. PubMed ID: 12591264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, conformation and biological activity of a novel lipodepsipeptide from Pseudomonas corrugata: cormycin A.
    Scaloni A; Dalla Serra M; Amodeo P; Mannina L; Vitale RM; Segre AL; Cruciani O; Lodovichetti F; Greco ML; Fiore A; Gallo M; D'Ambrosio C; Coraiola M; Menestrina G; Graniti A; Fogliano V
    Biochem J; 2004 Nov; 384(Pt 1):25-36. PubMed ID: 15196052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational studies of cyclic enkephalin analogues with L- or D-proline in position 3.
    Malicka J; Groth M; Czaplewski C; Wiczk W; Liwo A
    Biopolymers; 2002 Apr; 63(4):217-31. PubMed ID: 11807749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The siderophores of Pseudomonas fluorescens 18.1 and the importance of cyclopeptidic substructures for the recognition at the cell surface.
    Amann C; Taraz K; Budzikiewicz H; Meyer JM
    Z Naturforsch C J Biosci; 2000; 55(9-10):671-80. PubMed ID: 11098814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
    Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
    Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of cyclic lipopeptides by Pseudomonas fluorescens strains in bulk soil and in the sugar beet rhizosphere.
    Nielsen TH; Sørensen J
    Appl Environ Microbiol; 2003 Feb; 69(2):861-8. PubMed ID: 12571005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
    Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
    J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives.
    Kawulka KE; Sprules T; Diaper CM; Whittal RM; McKay RT; Mercier P; Zuber P; Vederas JC
    Biochemistry; 2004 Mar; 43(12):3385-95. PubMed ID: 15035610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.
    Ueda S; Oishi S; Wang ZX; Araki T; Tamamura H; Cluzeau J; Ohno H; Kusano S; Nakashima H; Trent JO; Peiper SC; Fujii N
    J Med Chem; 2007 Jan; 50(2):192-8. PubMed ID: 17228861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational analysis of furanoid epsilon-sugar amino acid containing cyclic peptides by NMR spectroscopy, molecular dynamics simulation, and X-ray crystallography: evidence for a novel turn structure.
    van Well RM; Marinelli L; Altona C; Erkelens K; Siegal G; van Raaij M; Llamas-Saiz AL; Kessler H; Novellino E; Lavecchia A; van Boom JH; Overhand M
    J Am Chem Soc; 2003 Sep; 125(36):10822-9. PubMed ID: 12952461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.